Look-alike, sounding similar drugs likely to face strict action

Earlier, in January India's Drug Technical Advisory Board (DTAB), India's apex drug advisory body, deliberated on the issue of same brand name (including look-alike and sound-alike ones) for different category of products and it suggested that to ensure patient safety, the manufacturing and marketing of different drugs with same brand name should "not be allowed."

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/FsGi9Vb
via IFTTT